| Enantioselective gold catalysis: opportunities provided by monodentate phosphoramidite ligands with an acyclic TADDOL backbone H Teller, S Flügge, R Goddard, A Fürstner Angewandte Chemie, International Edition 49 (11), 1949-1953, 2010 | 281 | 2010 |
| One-point binding ligands for asymmetric gold catalysis: phosphoramidites with a TADDOL-related but acyclic backbone H Teller, M Corbet, L Mantilli, G Gopakumar, R Goddard, W Thiel, ... Journal of the American Chemical Society 134 (37), 15331-15342, 2012 | 238 | 2012 |
| Concise synthesis of the antidepressive drug candidate GSK1360707 by a highly enantioselective gold-catalyzed enyne cycloisomerization reaction H Teller, A Fürstner Chemistry–A European Journal 17 (28), 7764-7767, 2011 | 104 | 2011 |
| Titanium Binolate Catalyzed Aminolysis of meso Aziridines: A Highly Enantioselective and Direct Access to 1,2‐Diamines S Peruncheralathan, H Teller, C Schneider Angewandte Chemie International Edition 48 (26), 4849-4852, 2009 | 60 | 2009 |
| An efficient synthesis of nitrogen-containing heterocycles via a tandem carbenoid N–H insertion/ring-closing metathesis sequence O Pavlyuk, H Teller, MC McMills Tetrahedron Letters 50 (23), 2716-2718, 2009 | 58 | 2009 |
| Catalytic asymmetric transformations of racemic aziridines Z Chai Synthesis 52 (12), 1738-1750, 2020 | 34 | 2020 |
| The Ti-BINOLate-catalyzed, enantioselective ring-opening of meso-aziridines with amines S Peruncheralathan, S Aurich, H Teller, C Schneider Organic & Biomolecular Chemistry 11 (17), 2787-2803, 2013 | 31 | 2013 |
| Synomag®: The new high-performance tracer for magnetic particle imaging P Vogel, T Kampf, MA Rückert, C Grüttner, A Kowalski, H Teller, V Behr Int J Magn Part Imaging 7, 1-6, 2021 | 17 | 2021 |
| Rapid Analysis of Cell–Nanoparticle Interactions using Single‐Cell Raman Trapping Microscopy M Steinke, F Zunhammer, EI Chatzopoulou, H Teller, K Schütze, H Walles, ... Angewandte Chemie International Edition 57 (18), 4946-4950, 2018 | 14 | 2018 |
| Design and preclinical characterization program toward asundexian (BAY 2433334), an oral factor XIa inhibitor for the prevention and treatment of thromboembolic disorders S Roehrig, J Ackerstaff, E Jiménez Núñez, H Teller, P Ellerbrock, K Meier, ... Journal of medicinal chemistry 66 (17), 12203-12224, 2023 | 13 | 2023 |
| Asymmetric titanium-catalyzed cyclopropanation of nitriles with Grignard reagents J Caillé, P Setzer, F Boeda, MSM Pearson-Long, P Bertus SynOpen 2 (01), 0041-0049, 2018 | 12 | 2018 |
| Titan‐Binolat‐katalysierte Aminolyse von meso‐Aziridinen–ein hochenantioselektiver und direkter Zugang zu 1, 2‐Diaminen S Peruncheralathan, H Teller, C Schneider Angewandte Chemie 121 (26), 4943-4946, 2009 | 12 | 2009 |
| Assessing hyperthermia performance of hybrid textile filaments: The impact of different heating agents B Mues, B Bauer, J Ortega, EM Buhl, H Teller, T Gries, T Schmitz-Rode, ... Journal of Magnetism and Magnetic Materials 519, 167486, 2021 | 11 | 2021 |
| Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders S Röhrig, A Hillisch, J Straβburger, S Heitmeier, MV Schmidt, ... US Patent 9,434,690, 2016 | 11 | 2016 |
| Using magnetic nanoparticles and protein–protein interactions to measure pH at the nanoscale SW Gordon-Wylie, C Grüttner, H Teller, JB Weaver IEEE Sensors Letters 4 (3), 1-3, 2020 | 9 | 2020 |
| Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders S Röhrig, A Hillisch, J Strassburger, S Heitmeier, MV Schmidt, ... US Patent 9,822,102, 2017 | 8 | 2017 |
| Biocompatibility of magnetic iron oxide nanoparticles for biomedical applications C Matschegewski, A Kowalski, K Müller, H Teller, N Grabow, S Großmann, ... Current Directions in Biomedical Engineering 5 (1), 573-576, 2019 | 7 | 2019 |
| Positive allosteric modulators of muscarinic M2 receptor H Teller, A Straub, M Brechmann, T Müller, M Meininghaus, ... US Patent 10,435,403, 2019 | 6 | 2019 |
| Substituted oxopyridine derivatives S Röhrig, A Hillisch, J Strassburger, S Heitmeier, MV Schmidt, ... US Patent 9,765,070, 2017 | 6 | 2017 |
| Substituted oxopyridine derivatives and use thereof as factor xia/plasma S Röhrig, A Hillisch, J Straβburger, S Heitmeier, MV Schmidt, ... US Patent 9,475,809, 2016 | 6 | 2016 |
